Aerosols

NasalGuard® 'Breathe Easier Healthcare Donation Program' Applauded by Frontline Healthcare Workers. Program Continues and Expands to Include Airline Workers and Frequent Travelers

Retrieved on: 
Thursday, July 9, 2020
Articles, Nature, Aerosols, Air pollution, Particulates, Pollutants, Visibility, Particle

SOMERVILLE, N.J., July 9, 2020 /PRNewswire/ --The NasalGuard Airborne Particle Blocker 'Breathe Easier Healthcare Workers Donation program' has received praise from frontline healthcare workers since the program launch in May.

Key Points: 
  • SOMERVILLE, N.J., July 9, 2020 /PRNewswire/ --The NasalGuard Airborne Particle Blocker 'Breathe Easier Healthcare Workers Donation program' has received praise from frontline healthcare workers since the program launch in May.
  • All requests are considered and all that is needed is a statement of profession, doctor office/hospital, airline employee status and quantity needed.
  • During these uncertain times, NasalGuard is a unique product that can help people protect themselves from harmful airborne particles!
  • Now with travel season in full swing and the pandemic continued uncertainty, NasalGuard has expanded to support Airline Workers and Frequent Travelers.

Global Nebulizers Market (2020 to 2025) - Outlook and Forecast

Retrieved on: 
Wednesday, July 8, 2020
Health, Companies, Respiratory therapy, Dosage forms, Medical equipment, Aerosols, Nebulizer, Omron, Philips, Market

DUBLIN, July 8, 2020 /PRNewswire/ -- The "Nebulizers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 8, 2020 /PRNewswire/ -- The "Nebulizers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The global nebulizer market is one of the steady growing segments in the global medical devices market.
  • The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices.
  • OMRON, Koninklijke Philips, Drive DeVilbiss International, PARI, Feellife Health, Besco Medical, and Rossmax International, and Ca-Mi are the key market players dominating the market.

Insights on the Nebulizers Global Market to 2025 - Featuring Big Eagle, Bremed & Well Swiss Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 6, 2020
Medical devices, Health, Respiratory therapy, Health, Aerosols, Dosage forms, Medical equipment, Nebulizer, Medicine

The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.

Key Points: 
  • The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.
  • The global nebulizer market is one of the steady growing segments in the global medical devices market.
  • According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.
  • The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices.

Smart Inhalers Market Size to Reach USD 1406 Million by 2026 - Valuates Reports

Retrieved on: 
Wednesday, July 1, 2020
Dosage forms, Respiratory therapy, Health, Medicine, Aerosols, Medical equipment, Nebulizer, Inhaler

The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.

Key Points: 
  • The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.
  • The global Dry Powder Inhalers market size is valued at 3201.1 Million USD in 2020 is expected to reach 3632 Million USD by the end of 2026, growing at a CAGR of 1.8% during 2021-2026.
  • The global Digital Dose Inhaler market size is projected to reach USD 1384.4 Million by 2026, from USD 1244 Million in 2020, at a CAGR of 10.4%% during 2021-2026.
  • The global Respiratory Inhalers market size is projected to reach USD 29220 Million by 2026, from USD 28800 Million in 2020, at a CAGR of 1.3%% during 2021-2026.

Smart Inhalers Market Size to Reach USD 1406 Million by 2026 - Valuates Reports

Retrieved on: 
Wednesday, July 1, 2020
Dosage forms, Respiratory therapy, Health, Medicine, Aerosols, Medical equipment, Nebulizer, Inhaler

The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.

Key Points: 
  • The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.
  • The global Dry Powder Inhalers market size is valued at 3201.1 Million USD in 2020 is expected to reach 3632 Million USD by the end of 2026, growing at a CAGR of 1.8% during 2021-2026.
  • The global Digital Dose Inhaler market size is projected to reach USD 1384.4 Million by 2026, from USD 1244 Million in 2020, at a CAGR of 10.4%% during 2021-2026.
  • The global Respiratory Inhalers market size is projected to reach USD 29220 Million by 2026, from USD 28800 Million in 2020, at a CAGR of 1.3%% during 2021-2026.

AKWEL AND TALLANO FORM PARTNERSHIP TO SCALE UP AND COMMERCIALISE AN INNOVATIVE SOLUTION FOR CAPTURING FINE PARTICLES DURING VEHICLE BRAKING

Retrieved on: 
Wednesday, July 1, 2020
Articles, Nature, Aerosols, Air pollution, Particulates, Pollutants, Visibility, Particle

AKWEL has formed a partnership with Tallano Technologie, which has developed and patented the TAMIC solution, a system for collecting harmful micro-particles emitted during vehicle braking, reducing particle emissions by 85 to 90%.

Key Points: 
  • AKWEL has formed a partnership with Tallano Technologie, which has developed and patented the TAMIC solution, a system for collecting harmful micro-particles emitted during vehicle braking, reducing particle emissions by 85 to 90%.
  • Operating in 20countries across every continent, AKWEL employs almost 12,000people worldwide.
  • Founded in 2012 and led by Christophe Rocca-Serra and Jean-Louis Juchault, Tallano Technologie offers an innovative solution for trapping fine particles at source during vehicle braking.
  • Tallano is actively supported by investors from the manufacturing and transportation industries.

2020 Global Forecast for Underarm Deodorants, Aerosol and Spray Type to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 25, 2020
Cosmetics, Retail, Statistical forecasting, Aerosols, Deodorant, Forecasting, Business, Economy

The "2020 Global Forecast for Underarm Deodorants, Aerosol and Spray Type (2021-2026 Outlook)-Manufacturing & Markets Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Global Forecast for Underarm Deodorants, Aerosol and Spray Type (2021-2026 Outlook)-Manufacturing & Markets Report" report has been added to ResearchAndMarkets.com's offering.
  • This report contains timely and accurate market statistics and forecasts on the market for over 140 countries.
  • Estimates on equipment or material sales (product shipments value) are published historically for 2013 to 2017, projections for 2016 to 2020 and forecasts for 2021 to 2026.
  • Product shipments value are presented in US Dollars and local currency units for historical and forecast years.

Native Deodorant Creates Safe Environment In "Pits" Of Loved Ones

Retrieved on: 
Tuesday, June 23, 2020
Software, Operating systems, Social media, Aerosols, Deodorant, Instagram, Loved Ones, Alum

"In the early phases of the campaign, we realized that, now more than ever, keeping our loved ones physically close is significant," said Vineet Kumar, CEO of Native.

Key Points: 
  • "In the early phases of the campaign, we realized that, now more than ever, keeping our loved ones physically close is significant," said Vineet Kumar, CEO of Native.
  • "Each piece of creative feels like a candid, un-staged home video captured by the families and loved ones featured in the spots."
  • Best known for its aluminum-free deodorant, Native exponentially grew the natural deodorant category.
  • For more information, visit www.nativecos.com , or you can follow Native on Facebook , Twitter , or Instagram .

Assessment of COVID-19's Effect on Nebulizers Market 2020-2024 | Demand for Nebulizers in Home Care Settings to Augment Growth | Technavio

Retrieved on: 
Monday, June 22, 2020
Medical devices, Health, Health, Aerosols, Medical equipment, Nebulizer, Respiratory therapy, Medicine, Systems thinking

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities.
  • Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
  • Demand for nebulizers in home care settings has been instrumental in driving the growth of the market.

Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy for Patients with Pulmonary Arterial Hypertension to Their Pipeline

Retrieved on: 
Monday, June 8, 2020
Health, Chippenham, Vectura Group, Articles, Aerosols, Dosage forms, Medical equipment, Respiratory therapy, Nebulizer, Royalty payment, Clinician

Aerami will be responsible for the overall development and commercialization of inhaled imatinib, with Vectura providing a combination of its development services expertise and a license to its FOX mesh nebulizer technology.

Key Points: 
  • Aerami will be responsible for the overall development and commercialization of inhaled imatinib, with Vectura providing a combination of its development services expertise and a license to its FOX mesh nebulizer technology.
  • The drug device combination product is targeted to go into a Phase 1 trial in the second half of 2020.
  • In return for the license, the Company will be obligated to pay Vectura certain regulatory and net sales-based milestones, a mid-single digit royalty on global net sales and will purchase FOX devices from Vectura.
  • We look forward to working with Vectura, the PAH patient and clinician community to initiate clinical development this year."